Clinical Trials Browser

Unknown × Thyroid Neoplasms × apatinib × Clear all

NCT04612894 2020-11-03

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms

NCT03300765 2017-10-03

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms